Clinical Trial Update: Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008 [Phase 2]

View source ↗

Summary

Phase 2 trial update on ALX-0600 for Crohn's disease completed; safety and efficacy data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• ALX-0600

Snippet

Sponsor: Shire | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED